Abstract:Background: The neuromuscular junction (NMJ) is a peripheral synapse critical to muscle contraction. Like acetylcholine receptors (AChRs), many essential proteins of NMJ are extremely concentrated at the postjunctional membrane. However, the mechanisms of synapse-specific concentration are not well understood; furthermore, it is unclear whether signaling molecules critical to NMJ formation and maintenance are also locally transcribed. Results: We studied the β-gal activity encoded by a lacZ cassette driven by the promoter of the Lrp4 gene. As reported for Lrp4 mRNA, β-gal was in the central region in embryonic muscles and at the NMJ after its formation. However, β-gal was no longer in the central areas of muscle fibers in Lrp4 or MuSK mutant mice, indicating a requirement of Lrp4/MuSK signaling. This phenotype could be rescued by transgenic expression of LRP4 with a transmembrane domain but not soluble ECD in Lrp4 mutant mice. β-gal and AChR clusters were distributed in a broader region in lacZ/ECD than that of heterozygous lacZ/+ mice, indicating an important role of the transmembrane domain in Lrp4 signaling. Synaptic β-gal activity became diffused after denervation or treatment with µ-conotoxin, despite its mRNA was increased, indicating synaptic Lrp4 mRNA enrichment requires muscle activity. β-gal was also diffused in aged mice but became re-concentrated after muscle stimulation. Finally, Lrp4 mRNA was increased in C2C12 myotubes by Wnt ligands in a manner that could be inhibited by RKI-1447, an inhibitor of ROCK in Wnt non-canonical signaling. Injecting RKI-1447 into muscles of adult mice diminished Lrp4 synaptic expression. Conclusions: This study demonstrates that synapse-specific enrichment of Lrp4 mRNA requires a coordinated interaction between Lrp4/MuSK signaling, muscle activity, and Wnt non-canonical signaling. Thus, the study provides a new mechanism for Lrp4 mRNA enrichment. It also provides a potential target for the treatment of NMJ aging and other NMJ-related diseases.

Lrp4 Serves As A Coreceptor of Agrin

LRP4 is critical for neuromuscular junction maintenance.

Distinct Roles of Muscle and Motoneuron LRP4 in Neuromuscular Junction Formation

Structural basis of agrin-LRP4-MuSK signaling.

Characterization of LRP4/Agrin Antibodies From a Patient With Myasthenia Gravis

Agrin/Lrp4 signal constrains MuSK-dependent neuromuscular synapse development in appendicular muscle

Antibodies Against Low-Density Lipoprotein Receptor-Related Protein 4 Induce Myasthenia Gravis.

Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy

LRP4-related signalling pathways and their regulatory role in neurological diseases

LRP4 in Neuromuscular Junction and Bone Development and Diseases.

Muscle-Specific Receptor Tyrosine Kinase Endocytosis in Acetylcholine Receptor Clustering in Response to Agrin

APC2CDH1negatively Regulates Agrin Signaling by Promoting the Ubiquitination and Proteolytic Degradation of DOK7

Agrin and Low-Density Lipoprotein-Related Receptor Protein 4 Antibodies in Amyotrophic Lateral Sclerosis Patients

Synapse-specific Lrp4 mRNA enrichment requires Lrp4/MuSK signaling, muscle activity and Wnt non-canonical pathway

Ablation of Lrp4 in Schwann Cells Promotes Peripheral Nerve Regeneration in Mice.

A Mechanism in Agrin Signaling Revealed by a Prevalent Rapsyn Mutation in Congenital Myasthenic Syndrome.

Structural insights into the assembly of the agrin/LRP4/MuSK signaling complex

Muscle-wide Secretion of a Miniaturized Form of Neural Agrin Rescues Focal Neuromuscular Innervation in Agrin Mutant Mice.

Differential Regulation of AChR Clustering in the Polar and Equatorial Region of Murine Muscle Spindles.

The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction